glp-1 data trends 2025: real-world data, patient outcomes & future therapies GLP-1 Drugs: Bridging Satiety, Nutrition,

Exenatide showed a beneficial effect on cardiovascular outcomes, albeit with borderline significance (Holman et al., 2017), whereas a separate trial of lixisenatide found no evidence of benefit (Pfeffer et al., 2015)

The frequency of these visits can vary, but usually are once a month in the beginning

It is also effective for neuropathy, delayed wound healing, scurvy, and symptoms like weakness, fatigue, and reduced immunity caused by vitamin deficiencies

Im hardly eating and have not had any side effects

If you feel cold or if you are experiencing the chills while taking your GLP-1 RA medication, it is important to talk with your healthcare provider

Cell Host Microbe 31 , 10381053.e10 (2023)